HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
T J Hollingsworth Selected Research
T J Hollingsworth Research Topics
Disease
3
Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2021 - 01/2012
3
Macular Degeneration (Age-Related Maculopathy)
12/2019 - 01/2015
2
Retinal Degeneration
10/2013 - 01/2012
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1
Neoplasms (Cancer)
06/2021
1
Adenocarcinoma
06/2021
1
Neoplasm Metastasis (Metastasis)
06/2021
1
Rheumatoid Arthritis
01/2021
1
Blindness (Hysterical Blindness)
01/2020
1
Disease Progression
01/2020
1
Retinal Diseases
12/2019
1
Genomic Instability
01/2019
1
Catalepsy
01/2019
1
Tardive Dyskinesia
01/2019
1
Psychotic Disorders (Schizoaffective Disorder)
01/2019
Drug/Important Bio-Agent (IBA)
4
Rhodopsin (Visual Purple)
IBA
01/2021 - 01/2012
2
Retinaldehyde (Retinal)
IBA
01/2022 - 01/2021
2
Proteins (Proteins, Gene)
FDA Link
06/2021 - 01/2012
2
Antigens
IBA
01/2017 - 01/2015
1
Transforming Growth Factor beta (TGF-beta)
IBA
06/2021
1
LY-2157299
IBA
06/2021
1
Gemcitabine
FDA Link
06/2021
1
Ligands
IBA
06/2021
1
Fluorescein (Funduscein)
FDA Link
Generic
01/2020
1
Pharmaceutical Preparations
IBA
01/2020
1
Polysaccharides (Glycans)
IBA
12/2019
1
Haloperidol (Haldol)
FDA Link
Generic
01/2019
1
Dopamine D2 Receptors (Dopamine D2 Receptor)
IBA
01/2019
1
Histones (Histone)
IBA
01/2019
1
CD5 Antigens
IBA
01/2017
1
Staphylococcal Protein A (Protein A)
IBA
01/2017
1
Autoantigens
IBA
01/2017
1
Antibodies
IBA
01/2017
1
Autoantibodies
IBA
01/2015
Therapy/Procedure
1
Therapeutics
12/2019
1
Immunomodulation
01/2015